Randomized controlled trial for the management of osteoporosis in inflammatory bowel disease
Not Applicable
- Conditions
- Inflammatory bowel disease
- Registration Number
- JPRN-UMIN000006915
- Lead Sponsor
- Department of Gastroenterology, Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients already treated for osteoporosis 2) Patients taking warfarin. 3) Patients with stenosis in the esophagus or gut. 4) Patients allergic to medicine. 5) Patients who cannot stand or sit down for more than 30 min. 6) Pregnancy. 7) Patients with severe nephropathy. 8) Patients who are attending other clinical trials. 9) Patients who are not supposed to be suitable for this study by doctors.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bone mineral density 12 months after the treatment
- Secondary Outcome Measures
Name Time Method Bone mineral density 12 months after the treatment. Bone markers, disease activity, side effects.